Renal hypoxia and dysoxia after reperfusion of the ischemic kidney

Molecular Medicine

Volumn 14, Issue 7-8, 2008, Pages 502-516

  Legrand, Matthieu ^a,b   Mik, Egbert G ^c   Johannes, Tanja ^d   Payen, Didier ^b   Ince, Can ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b HÔPITAL LARIBOISIÈRE   (France)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ADENOSINE DIPHOSPHATE RIBOSE; ADENOSINE RECEPTOR BLOCKING AGENT; ALPHA INTERMEDIN; CD11 ANTIGEN; CD18 ANTIGEN; CYTOCHROME P450; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; ERYTHROPOIETIN; FENOLDOPAM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; LIPOXYGENASE; LOOP DIURETIC AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NORADRENALIN; PADGEM PROTEIN; PROSTANOID; STARCH; TETRAHYDROBIOPTERIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASOCONSTRICTOR AGENT; VASODILATOR AGENT; VASOPRESSIN;

ACUTE KIDNEY FAILURE; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CAPILLARY FLOW; CELL ACTIVITY; CELL INFILTRATION; CELL INTERACTION; CHEMOTAXIS; DNA REPAIR; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; MICROVASCULARIZATION; MITOCHONDRIAL RESPIRATION; NEPHRITIS; NEUTROPHIL; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN SUPPLY; OXYGEN TRANSPORT; PRIORITY JOURNAL; RENAL DYSOXIA; RENAL HYPOXIA; RENAL PROTECTION; REPERFUSION; REVIEW; SYMPATHETIC NERVE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANOXIA; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE, ACUTE; MODELS, BIOLOGICAL; OXYGEN CONSUMPTION; REPERFUSION; REPERFUSION INJURY; VASOCONSTRICTION; VASODILATION;

EID: 48149111863     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2008-00006.Legrand     Document Type: Review

References (222)

1. Brady HR, Singer GG. (1995) Acute renal failure. Lancet 346:1533-40.
2. Bagshaw SM. (2006) The long-term outcome after acute renal failure. Curr. Opin. Crit. Care 12:561-6.
3. Korkeila M, Ruokonen E, Takala J. (2000) Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med. 26:1824-31.
4. Manns B, et al. (2003) Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit. Care Med. 31:449-55.
5. Bell M, Martling CR. (2007) Long-term outcome after intensive care: can we protect the kidney? Crit. Care 11:147.
6. Hoste EA, Kellum JA. (2006) Acute kidney injury: epidemiology and diagnostic criteria. Curr. Opin. Crit. Care 12:531-7.
7. Ellenberger C, et al. (2006) Incidence, risk factors and prognosis of changes in serum creatinine early after aortic abdominal surgery. Intensive Care Med. 32:1808-16.
8. Wong GT, Irwin MG. (2007) Contrast-induced nephropathy. Br. J. Anaesth. 99:474-83.
9. Eckardt KU, et al. (2005) Role of hypoxia in the pathogenesis of renal disease. Kidney Int. Suppl. S46-51.
10. Leong CL, Anderson WP, O'Connor PM, Evans RG. (2007) Evidence that renal arterial-venous oxygen shunting contributes to dynamic regulation of renal oxygenation. Am. J. Physiol. Renal Physiol. 292:F1726-33.
11. 123I-hippuran handling. Am. J. Physiol. 269:F571-80.
12. Pallone TL, Robertson CR, Jamison RL. (1990) Renal medullary microcirculation. Physiol. Rev. 70:885-920.
13. Pallone TL, Silldorff EP, Turner MR. (1998) Intrarenal blood flow: microvascular anatomy and the regulation of medullary perfusion. Clin. Exp. Pharmacol. Physiol. 25:383-92.
14. Joo JD, et al. (2007) Acute and delayed renal protection against renal ischemia and reperfusion injury with A1 adenosine receptors. Am. J. Physiol. Renal Physiol. 293:F1847-57.
15. Whitehouse T, Stotz M, Taylor V, Stidwill R, Singer M. (2006) Tissue oxygen and hemodynamics in renal medulla, cortex, and corticomedullary junction during hemorrhage-reperfusion. Am. J. Physiol. Renal Physiol. 291:F647-53.
16. Rosen S, Epstein FH, Brezis M. (1992) Determinants of intrarenal oxygenation: factors in acute renal failure. Ren. Fail. 14:321-5.
17. Cohen JJ. (1979) Is the function of the renal papilla coupled exclusively to an anaerobic pattern of metabolism? Am. J. Physiol. 236:F423-33.
18. Pallone TL, Zhang Z, Rhinehart K. (2003) Physiology of the renal medullary microcirculation. Am. J. Physiol. Renal Physiol. 284:F253-66.
19. Brezis M, Rosen S. (1995) Hypoxia of the renal medulla: its implications for disease. N. Engl. J. Med. 332:647-55.
20. Sutton TA, Mang HE, Campos SB, Sandoval RM, Yoder MC, Molitoris BA. (2003) Injury of the renal microvascular endothelium alters barrier function after ischemia. Am. J. Physiol. Renal Physiol. 285:F191-8.
21. Yamamoto T, et al. (2002) Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am. J. Physiol. Renal Physiol. 282:F1150-5.
22. Horbelt M, et al. (2007) Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am. J. Physiol. Renal Physiol. 293:F688-95.
23. Jassem W, Fuggle SV, Rela M, Koo DD, Heaton ND. (2002) The role of mitochondria in ischemia/reperfusion injury. Transplantation 73:493-9.
24. Pan Y, et al. (2007) Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol. Cell. Biol. 27:912-25.
25. Coremans JM, Van Aken M, Naus DC, Van Velthuysen ML, Bruining HA, Puppels GJ. (2000) Pretransplantation assessment of renal viability with NADH fluorimetry. Kidney Int. 57:671-83.
26. Lameire N, Van Biesen W, Vanholder R. (2005) Acute renal failure. Lancet 365:417-30.
27. Rosen S, Heyman SN. (2001) Difficulties in understanding human "acute tubular necrosis": limited data and flawed animal models. Kidney Int. 60:1220-4.
28. Schnackenberg CG. (2002) Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282:R335-42.
29. Li C, Jackson RM. (2002) Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell Physiol. 282:C227-41.
30. Schrier RW, Wang W, Poole B, Mitra A. (2004) Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J. Clin. Invest. 114:5-14.
31. 2. J. Appl. Physiol. 68:833-42.
32. Sutton TA, Fisher CJ, Molitoris BA. (2002) Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 62:1539-49.
33. Arendshorst WJ, Finn WF, Gottschalk CW. (1975) Pathogenesis of acute renal failure following temporary renal ischemia in the rat. Circ. Res. 37:558-68.
34. Olof P, Hellberg A, Kallskog O, Wolgast M. (1991) Red cell trapping and postischemic renal blood flow: differences between the cortex, outer and inner medulla. Kidney Int. 40:625-31.
35. Mason J, Torhorst J, Welsch J. (1984) Role of the medullary perfusion defect in the pathogenesis of ischemic renal failure. Kidney Int. 26:283-93.
36. Thiel G, de Rougemont D, Kriz W, Mason J, Torhorst J, Wolgast M. (1982) The role of reduced medullary perfusion in the genesis of acute ischemic renal failure: summary of a round-table discussion. Nephron 31:321-3.
37. Summers WK, Jamison RL. (1971) The no reflow phenomenon in renal ischemia. Lab. Invest. 25:635-43.
38. 2 in a normotensive rat model of endotoxemia. Crit. Care 10:R88.
39. Johannes T, Mik EG, Ince C. (2008) Nonresuscitated endotoxemia induces microcirculatory hypoxic areas in the renal cortex in the rat. Shock. 2008, May 19 [Epub ahead of print].
40. Pallone TL, Silldorff EP. (2001) Pericyte regulation of renal medullary blood flow. Exp. Nephrol. 9:165-70.
41. Molitoris BA, Sandoval R, Sutton TA. (2002) Endothelial injury and dysfunction in ischemic acute renal failure. Crit. Care Med. 30:S235-40.
42. Kone BC, Baylis C. (1997) Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am. J. Physiol. 272:F561-78.
43. Guan Z, Gobe G, Willgoss D, Endre ZH. (2006) Renal endothelial dysfunction and impaired autoregulation after ischemia-reperfusion injury result from excess nitric oxide. Am. J. Physiol. Renal Physiol. 291:F619-28.
44. Ito S, Abe K. (1997) Contractile properties of afferent and efferent arterioles. Clin. Exp. Pharmacol. Physiol 24:532-5.
45. Cowley AW Jr, Mori T, Mattson D, Zou AP. (2003) Role of renal NO production in the regulation of medullary blood flow. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284:R1355-69.
46. Wu F, Park F, Cowley AW Jr, Mattson DL. (1999) Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney. Am. J. Physiol. 276:F874-81.
47. Arima S, Ito S. (2000) Isolated juxtaglomerular apparatus as a tool for exploring glomerular hemodynamics: application of microperfusion techniques. Exp. Nephrol. 8:304-11.
48. Kone BC. (1999) Localization and regulation of nitric oxide synthase isoforms in the kidney. Semin. Nephrol. 19:230-41.
49. Buttery LD, Evans TJ, Springall DR, Carpenter A, Cohen J, Polak JM. (1994) Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab. Invest. 71:755-64.
50. Tojo A, et al. (1994) Immunocytochemical localization of distinct isoforms of nitric oxide synthase in the juxtaglomerular apparatus of normal rat kidney. J. Am. Soc. Nephrol. 4:1438-47.
51. Brown R, Ollerstam A, Persson AE. (2004) Neuronal nitric oxide synthase inhibition sensitizes the tubuloglomerular feedback mechanism after volume expansion. Kidney Int. 65:1349-56.
52. Grzelec-Mojzesowicz M, Sadowski J. (2007) Renal tissue NO and intrarenal haemodynamics during experimental variations of NO content in anaesthetised rats. J. Physiol. Pharmacol. 58:149-63.
53. Ito S, Carretero OA, Abe K. (1997) Role of nitric oxide in the control of glomerular microcirculation. Clin. Exp. Pharmacol. Physiol. 24:578-81.
54. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M. (1994) Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J. Clin. Invest. 94:1069-75.
55. Goligorsky MS, Brodsky SV, Noiri E. (2004) NO bioavailability, endothelial dysfunction, and acute renal failure: new insights into pathophysiology. Semin. Nephrol. 24:316-23.
56. Gunnett CA, Lund DD, McDowell AK, Faraci FM, Heistad DD. (2005) Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction. Arterioscler. Thromb. Vasc. Biol. 25:1617-22.
57. Yu L, Gengaro PE, Niederberger M, Burke TJ, Schrier RW. (1994) Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc. Natl. Acad. Sci. U. S. A. 91:1691-5.
58. Noiri E, Peresleni T, Miller F, Goligorsky MS. (1996) In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J. Clin. Invest. 97:2377-83.
59. Chatterjee PK, et al. (2002) Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int. 61:862-71.
60. Wangsiripaisan A, Gengaro PE, Nemenoff RA, Ling H, Edelstein CL, Schrier RW. (1999) Effect of nitric oxide donors on renal tubular epithelial cell-matrix adhesion. Kidney Int. 55:2281-8.
61. Schild L, Reinheckel T, Reiser M, Horn TF, Wolf G, Augustin W. (2003) Nitric oxide produced in rat liver mitochondria causes oxidative stress and impairment of respiration after transient hypoxia. FASEB J. 17:2194-201.
62. Brezis M, Heyman SN, Dinour D, Epstein FH, Rosen S. (1991) Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. J. Clin. Invest. 88:390-5.
63. Chung AW, et al. (2004) Platelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases. Br. J. Pharmacol. 143:845-55.
64. Phelan MW, Faller DV. (1996) Hypoxia decreases constitutive nitric oxide synthase transcript and protein in cultured endothelial cells. J. Cell Physiol. 167:469-76.
65. Brodsky SV, et al. (2002) Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am. J. Physiol. Renal Physiol. 282:F1140-9.
66. Lieberthal W, Wolf EF, Rennke HG, Valeri CR, Levinsky NG. (1989) Renal ischemia and reperfusion impair endothelium-dependent vascular relaxation. Am. J. Physiol. 256:F894-900.
67. Rosenberger C, Rosen S, Heyman SN. (2006) Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clin. Exp. Pharmacol. Physiol. 33:980-8.
68. Rabelink TJ, van Zonneveld AJ. (2006) Coupling eNOS uncoupling to the innate immune response. Arterioscler. Thromb. Vasc. Biol. 26:2585-7.
69. Kakoki M, et al. (2000) Effects of tetrahydrobiopterin on endothelial dysfunction in rats with ischemic acute renal failure. J. Am. Soc. Nephrol. 11:301-9.
70. Bertuglia S, Giusti A. (2005) Role of nitric oxide in capillary perfusion and oxygen delivery regulation during systemic hypoxia. Am. J. Physiol. Heart Circ. Physiol. 288:H525-31.
71. Crawford JH, et al. (2006) Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 107:566-74.
72. Heyman SN, Goldfarb M, Darmon D, Brezis M. (1999) Tissue oxygenation modifies nitric oxide bioavailability. Microcirculation 6:199-203.
73. Jia L, Bonaventura C, Bonaventura J, Stamler JS. (1996) S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380:221-6.
74. Gladwin MT. (2006) Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation. Adv. Exp. Med. Biol. 588:189-205.
75. Conger J, Robinette J, Villar A, Raij L, Shultz P. (1995) Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats. J. Clin. Invest. 96:631-8.
76. Jerkic M, et al. (2004) Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure. Nephrol. Dial. Transplant. 19:83-94.
77. Masumura H, Kunitada S, Irie K, Ashida S, Abe Y. (1991) A thromboxane A2 synthase inhibitor, DP-1904, prevents rat renal injury. Eur. J. Pharmacol. 193:321-7.
78. Klausner JM, et al. (1989) Postischemic renal injury is mediated by neutrophils and leukotrienes. Am. J. Physiol. 256:F794-802.
79. Conger JD, Robinette JB, Schrier RW. (1988) Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J. Clin. Invest. 82:532-7.
80. Harriman JF, Liu XL, Aleo MD, Machaca K, Schnellmann RG. (2002) Endoplasmic reticulum Ca(2+) signaling and calpains mediate renal cell death. Cell Death Differ. 9:734-41.
81. Kurata H, et al. (2005) Protective effect of nitric oxide on ischemia/reperfusion-induced renal injury and endothelin-1 overproduction. Eur. J. Pharmacol. 517:232-9.
82. Forbes JM, Hewitson TD, Becker GJ, Jones CL. (2001) Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function. Kidney Int. 59:1333-41.
83. Hao CM, Breyer MD. (2007) Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int. 71:1105-15.
84. DiBona GF. (1986) Prostaglandins and nonsteroidal anti-inflammatory drugs: effects on renal hemodynamics. Am. J. Med. 80:12-21.
85. Catella-Lawson F, et al. (1999) Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J. Pharmacol. Exp. Ther. 289:735-41.
86. Llinas MT, Lopez R, Rodriguez F, Roig F, Salazar FJ. (2001) Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine. Am. J. Physiol. Renal Physiol. 281:F975-82.
87. Rodriguez F, Llinas MT, Gonzalez JD, Rivera J, Salazar FJ. (2000) Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake. Hypertension 36:276-81.
88. Ling H, et al. (1998) Effect of hypoxia on proximal tubules isolated from nitric oxide synthase knockout mice. Kidney Int. 53:1642-6.
89. Farge D, De la Coussaye JE, Beloucif S, Fratacci MD, Payen DM. (1995) Interactions between hemodynamic and hormonal modifications during PEEP-induced antidiuresis and antinatriuresis. Chest 107:1095-100.
90. Payen DM, et al. (1987) Hemodynamic, gas exchange, and hormonal consequences of LBPP during PEEP ventilation. J. Appl. Physiol. 62:61-70.
91. Imig JD. (2006) Eicosanoids and renal vascular function in diseases. Clin. Sci. (Lond.) 111:21-34.
92. Lewis RA, Austen KF, Soberman RJ. (1990) Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323:645-55.
93. Pace-Asciak CR, Asotra S. (1989) Biosynthesis, catabolism, and biological properties of HPETEs, hydroperoxide derivatives of arachidonic acid. Free Radic. Biol. Med. 7:409-33.
94. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN. (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237:1171-6.
95. Yiu SS, Zhao X, Inscho EW, Imig JD. (2003) 12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels. J. Lipid Res. 44:2391-9.
96. Katoh T, Takahashi K, DeBoer DK, Serhan CN, Badr KF. (1992) Renal hemodynamic actions of lipoxins in rats: a comparative physiological study. Am. J. Physiol. 263:F436-42.
97. Kwon O, et al. (1998) Backleak, tight junctions, and cell-cell adhesion in postischemic injury to the renal allograft. J. Clin. Invest. 101:2054-64.
98. Leemreis JR, Versteilen AM, Sipkema P, Groeneveld AB, Musters RJ. (2006) Digital image analysis of cytoskeletal F-actin disintegration in renal microvascular endothelium following ischemia/reperfusion. Cytometry A 69:973-8.
99. Genesca M, Sola A, Hotter G. (2006) Actin cytoskeleton derangement induces apoptosis in renal ischemia/reperfusion. Apoptosis 11:563-71.
100. Noll T, Muhs A, Besselmann M, Watanabe H, Piper HM. (1995) Initiation of hyperpermeability in energy-depleted coronary endothelial monolayers. Am. J. Physiol. 268:H1462-70.
101. Kevil CG, Oshima T, Alexander B, Coe LL, Alexander JS. (2000) H(2)O(2)-mediated permeability: role of MAPK and occludin. Am. J. Physiol. Cell Physiol. 279:C21-30.
102. Kevil CG, Oshima T, Alexander JS. (2001) The role of p38 MAP kinase in hydrogen peroxide mediated endothelial solute permeability. Endothelium 8:107-16.
103. Ochoa L, Waypa G, Mahoney JR Jr, Rodriguez L, Minnear FL. (1997) Contrasting effects of hypochlorous acid and hydrogen peroxide on endothelial permeability: prevention with cAMP drugs. Am. J. Respir. Crit. Care Med. 156:1247-55.
104. Basile DP, Donohoe D, Roethe K, Osborn JL. (2001) Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am. J. Physiol. Renal Physiol. 281:F887-99.
105. Sutton TA, Horbelt M, Sandoval RM. (2006) Imaging vascular pathology. Nephron Physiol. 103:p82-5.
106. Dejana E. (2004) Endothelial cell-cell junctions: happy together. Nat. Rev. Mol. Cell. Biol. 5:261-70.
107. Soullier S, Gayrard N, Méjean C, Swarcz I, Mourad G, Argilés A. (2005) Molecular mechanisms involved in kidney ischemia-reperfusion [in French]. Nephrol. Ther. 1:315-21.
108. Johnston WH, Latta H. (1977) Glomerular mesangial and endothelial cell swelling following temporary renal ischemia and its role in the no-reflow phenomenon. Am. J. Pathol. 89:153-66.
109. Flores J, DiBona DR, Beck CH, Leaf A. (1972) The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J. Clin. Invest. 51:118-26.
110. Nilius B, Droogmans G. (2001) Ion channels and their functional role in vascular endothelium. Physiol. Rev. 81:1415-59.
111. Orie NN, Fry CH, Clapp LH. (2006) Evidence that inward rectifier K+ channels mediate relaxation by the PGI2 receptor agonist cicaprost via a cyclic AMP-independent mechanism. Cardiovasc. Res. 69:107-15.
112. Bychkov R, et al. (1999) Hydrogen peroxide, potassium currents, and membrane potential in human endothelial cells. Circulation 99:1719-25.
113. Kramer AA, Postler G, Salhab KF, Mendez C, Carey LC, Rabb H. (1999) Renal ischemia/ reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int. 55:2362-7.
114. Okajima K. (2004) Prevention of endothelial cell injury by activated protein C: the molecular mechanism(s) and therapeutic implications. Curr. Vasc. Pharmacol. 2:125-33.
115. Peek GJ, Firmin RK. (1999) The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. ASAIO J. 45:250-63.
116. Xu XP, Pollock JS, Tanner MA, Myers PR. (1995) Hypoxia activates nitric oxide synthase and stimulates nitric oxide production in porcine coronary resistance arteriolar endothelial cells. Cardiovasc. Res. 30:841-7.
117. Aird WC. (2003) Endothelial cell heterogeneity. Crit. Care Med. 31:S221-30.
118. Stevens T, et al. (2001) NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases. Am. J. Physiol. Cell Physiol. 281:C1422-33.
119. Sheridan AM, Bonventre JV. (2000) Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr. Opin. Nephrol. Hypertens. 9:427-34.
120. Dragun D, Haller H. (1999) Diapedesis of leukocytes: antisense oligonucleotides for rescue. Exp. Nephrol. 7:185-92.
121. Burne-Taney MJ, Rabb H. (2003) The role of adhesion molecules and T cells in ischemic renal injury. Curr. Opin. Nephrol. Hypertens. 12:85-90.
122. Savransky V, Molls RR, Burne-Taney M, Chien CC, Racusen L, Rabb H. (2006) Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int. 69:233-8.
123. Ysebaert DK, et al. (2004) T cells as mediators in renal ischemia/reperfusion injury. Kidney Int. 66:491-6.
124. Friedewald JJ, Rabb H. (2004) Inflammatory cells in ischemic acute renal failure. Kidney Int. 66:486-91.
125. Thornton MA, Winn R, Alpers CE, Zager RA. (1989) An evaluation of the neutrophil as a mediator of in vivo renal ischemic-reperfusion injury. Am. J. Pathol. 135:509-15.
126. Paller MS. (1989) Effect of neutrophil depletion on ischemic renal injury in the rat. J. Lab. Clin. Med. 113:379-86.
127. Rabb H, O'Meara YM, Maderna P, Coleman P, Brady HR. (1997) Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int. 51:1463-8.
128. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL. (1997) The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J. Clin. Invest. 100:1199-203.
129. De Greef KE, et al. (2001) Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int. 60:1415-27.
130. Chandraker A, Takada M, Nadeau KC, Peach R, Tilney NL, Sayegh MH. (1997) CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int. 52:1678-84.
131. Rabb H, et al. (2000) Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am. J. Physiol. Renal Physiol. 279:F525-31.
132. Bonventre JV, Weinberg JM. (2003) Recent advances in the pathophysiology of ischemic acute renal failure. J. Am. Soc. Nephrol. 14:2199-210.
133. Rabb H, et al. (1994) Role of CD11a and CD11b in ischemic acute renal failure in rats. Am. J. Physiol. 267:F1052-8.
134. Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. (2007) Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ. Res. 101:234-7.
135. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA. (1997) Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J. Clin. Invest. 99:1165-72.
136. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR. (1999) Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am. J. Physiol. 277:R922-9.
137. Simmons EM, et al. (2004) Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int. 65:1357-65.
138. Martin DR, Lewington AJ, Hammerman MR, Padanilam BJ. (2000) Inhibition of poly(ADP-ribose) polymerase attenuates ischemic renal injury in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279:R1834-40.
139. Chatterjee PK, Zacharowski K, Cuzzocrea S, Otto M, Thiemermann C. (2000) Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo. FASEB J. 14:641-51.
140. Zheng J, Devalaraja-Narashimha K, Singaravelu K, Padanilam BJ. (2005) Poly(ADP-ribose) polymerase-1 gene ablation protects mice from ischemic renal injury. Am. J. Physiol. Renal Physiol. 288:F387-98.
141. Kota BP, Huang TH, Roufogalis BD. (2005) An overview on biological mechanisms of PPARs. Pharmacol. Res. 51:85-94.
142. Devalaraja-Narashimha K, Singaravelu K, Padanilam BJ. (2005) Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure. Pharmacol. Res. 52:44-59.
143. Kelly KJ, Williams WW Jr, Colvin RB, Bonventre JV. (1994) Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc. Natl. Acad. Sci. U. S. A. 91:812-6.
144. Molitoris BA, Marrs J. (1999) The role of cell adhesion molecules in ischemic acute renal failure. Am. J. Med. 106:583-92.
145. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. (1997) The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney: inhibition by a soluble Pselectin ligand. J. Clin. Invest. 99:2682-90.
146. Singbartl K, Forlow SB, Ley K. (2001) Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure. FASEB J. 15:2337-44.
147. Jayle C, et al. (2006) Protective role of selectin ligand inhibition in a large animal model of kidney ischemia-reperfusion injury. Kidney Int. 69:1749-55.
148. Burne-Taney MJ, Kofler J, Yokota N, Weisfeldt M, Traystman RJ, Rabb H. (2003) Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am. J. Physiol. Renal Physiol. 285:F87-94.
149. Lieberthal W. (1998) Biology of ischemic and toxic renal tubular cell injury: role of nitric oxide and the inflammatory response. Curr. Opin. Nephrol. Hypertens. 7:289-95.
150. Brezis M, Heyman SN, Epstein FH. (1994) Determinants of intrarenal oxygenation. II. Hemodynamic effects. Am. J. Physiol. 267:F1063-8.
151. O'Connor PM, Kett MM, Anderson WP, Evans RG. (2006) Renal medullary tissue oxygenation is dependent on both cortical and medullary blood flow. Am. J. Physiol. Renal Physiol. 290:F688-94.
152. Brezis M, Agmon Y, Epstein FH. (1994) Determinants of intrarenal oxygenation. I. Effects of diuretics. Am. J. Physiol. 267:F1059-62.
153. Koivisto A, Pittner J, Froelich M, Persson AE. (1999) Oxygen-dependent inhibition of respiration in isolated renal tubules by nitric oxide. Kidney Int. 55:2368-75.
154. - and is diminished by a high-salt diet. Am. J. Physiol. Renal Physiol. 287:F224-30.
155. Vinas JL, Sola A, Hotter G. (2006) Mitochondrial NOS upregulation during renal I/R causes apoptosis in a peroxynitrite-dependent manner. Kidney Int. 69:1403-9.
156. Moncada S, Erusalimsky JD. (2002) Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Cell. Biol. 3:214-20.
157. Laycock SK, et al. (1998) Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ. Res. 82:1263-71.
158. Gladwin MT, et al. (2006) Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation. Am. J. Physiol. Heart Circ. Physiol. 291:H2026-35.
159. Brown GC. (1995) Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett. 369:136-9.
160. Davidson SM, Duchen MR. (2006) Effects of NO on mitochondrial function in cardiomyocytes: pathophysiological relevance. Cardiovasc. Res. 71:10-21.
161. Boveris A, Costa LE, Poderoso JJ, Carreras MC, Cadenas E. (2000) Regulation of mitochondrial respiration by oxygen and nitric oxide. Ann. N. Y. Acad. Sci. 899:121-35.
162. Takehara Y, et al. (1996) Oxygen-dependent reversible inhibition of mitochondrial respiration by nitric oxide. Cell Struct. Funct. 21:251-8.
163. Toledo-Pereyra LH, Lopez-Neblina F, Toledo AH. (2004) Reactive oxygen species and molecular biology of ischemia/reperfusion. Ann. Transplant. 9:81-3.
164. 2, ROS, and NO during reperfusion. Adv. Exp. Med. Biol. 566:23-9.
165. Rubio-Gayosso I, Platts SH, Duling BR. (2006) Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 290:H2247-56.
166. Chandel NS, Budinger GR, Choe SH, Schumacker PT. (1997) Cellular respiration during hypoxia: role of cytochrome oxidase as the oxygen sensor in hepatocytes. J. Biol. Chem. 272:18808-16.
167. Brealey D, et al. (2004) Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286:R491-7.
168. Adler S, et al. (2001) Endothelial nitric oxide synthase plays an essential role in regulation of renal oxygen consumption by NO. Am. J. Physiol. Renal Physiol. 280:F838-43.
169. Clementi E, Brown GC, Foxwell N, Moncada S. (1999) On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc. Natl. Acad. Sci. U. S. A. 96:1559-62.
170. 2 measured by delayed fluorescence of endogenous protoporphyrin IX. Nat. Methods 3:939-45.
171. Rabelink TJ, Wijewickrama DC, de Koning EJ. (2007) Peritubular endothelium: the Achilles heel of the kidney? Kidney Int. 72:926-30.
172. Norman JT, Fine LG. (2006) Intrarenal oxygenation in chronic renal failure. Clin. Exp. Pharmacol. Physiol. 33:989-96.
173. Basile DP, Donohoe DL, Roethe K, Mattson DL. (2003) Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage. Am. J. Physiol. Renal Physiol. 284:F338-48.
174. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ. (2001) Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J. Am. Soc. Nephrol. 12:1448-57.
175. Yang J, et al. (2001) Telomerized human microvasculature is functional in vivo. Nat. Biotechnol. 19:219-24.
176. Sharples EJ, et al. (2004) Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J. Am. Soc. Nephrol. 15:2115-24.
177. Ribatti D, Nico B, Crivellato E, Vacca A. (2005) Endothelial progenitor cells in health and disease. Histol. Histopathol. 20:1351-8.
178. Basile DP. (2007) The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int. 72:151-6.
179. Li J, Deane JA, Campanale NV, Bertram JF, Ricardo SD. (2007) The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis. Stem Cells 25:697-706.
180. Rosenberger C, et al. (2006) Hypoxia-inducible factors and tubular cell survival in isolated perfused kidneys. Kidney Int. 70:60-70.
181. Rosenberger C, et al. (2005) Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia. Kidney Int. 67:531-42.
182. Safran M, Kaelin WG Jr. (2003) HIF hydroxylation and the mammalian oxygen-sensing pathway. J. Clin. Invest. 111:779-83.
183. Haase VH. (2006) The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease. Kidney Int. 69:1302-7.
184. Haase VH. (2006) Hypoxia-inducible factors in the kidney. Am. J. Physiol. Renal Physiol. 291:F271-81.
185. Mansfield KD, et al. (2005) Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab. 1:393-9.
186. Sandau KB, Fandrey J, Brune B. (2001) Accumulation of HIF-1alpha under the influence of nitric oxide. Blood 97:1009-15.
187. Hagen T, Taylor CT, Lam F, Moncada S. (2003) Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 302:1975-8.
188. Schrijvers BF, Flyvbjerg A, De Vriese AS. (2004) The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 65:2003-17.
189. Kanellis J, et al. (2002) Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression. Kidney Int. 61:1696-706.
190. Kim YG, et al. (2000) Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int. 58:2390-9.
191. Takahashi T, Morita K, Akagi R, Sassa S. (2004) Protective role of heme oxygenase-1 in renal ischemia. Antioxid. Redox. Signal. 6:867-77.
192. Shimizu H, et al. (2000) Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit. Care Med. 28:809-17.
193. Salom MG, et al. (2007) Heme oxygenase-1 induction improves ischemic renal failure: role of nitric oxide and peroxynitrite. Am. J. Physiol. Heart Circ. Physiol. 293:H3542-9.
194. Aydin Z, Duijs J, Bajema IM, van Zonneveld AJ, Rabelink TJ. (2007) Erythropoietin, progenitors, and repair. Kidney Int. 72 Suppl:S16-20.
195. Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT. (2004) Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104:2073-80.
196. Biju MP, Akai Y, Shrimanker N, Haase VH. (2005) Protection of HIF-1-deficient primary renal tubular epithelial cells from hypoxia-induced cell death is glucose dependent. Am. J. Physiol. Renal Physiol. 289:F1217-26.
197. Schofield CJ, Ratcliffe PJ. (2004) Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell. Biol. 5:343-54.
198. Rivers E, et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 345:1368-77.
199. Rivers EP, et al. (2007) The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit. Care Med. 35:2016-24.
200. Lameire NH, De Vriese AS, Vanholder R. (2003) Prevention and nondialytic treatment of acute renal failure. Curr. Opin. Crit. Care 9:481-90.
201. Venkataraman R, Kellum JA. (2007) Prevention of acute renal failure. Chest 131:300-8.
202. De Backer D, et al. (2006) The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit. Care Med. 34:403-8.
203. Schortgen F, et al. (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357:911-6.
204. Brunkhorst FM, et al. (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N. Engl. J. Med. 358:125-39.
205. Yuruk K, Almac E, Ince C. (2007) Hydroxyethyl starch solutions and their effect on the microcirculation and tissue oxygenation. Transfus. Altern. Transfus. Med. 9:164-72.
206. Blasco V, Leone M, Antonini F, Geissler A, Albanese J, Martin C. (2008) Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br. J. Anaesth. 100:504-8.
207. Sakr Y, et al. (2006) Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit. Care Med. 34:589-97.
208. Faivre V, et al. (2005) Cardiac and renal effects of levosimendan, arginine vasopressin, and norepinephrine in lipopolysaccharide-treated rabbits. Anesthesiology 103:514-21.
209. Albert M, Losser MR, Hayon D, Faivre V, Payen D. (2004) Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits. Crit. Care Med. 32:1891-8.
210. Gattinoni L, et al. (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N. Engl. J. Med. 333:1025-32.
211. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N. Engl. J. Med. 330:1717-22.
212. Durairaj L, Schmidt GA. (2008) Fluid therapy in resuscitated sepsis: less is more. Chest 133:252-63.
213. Thurau K, Boylan JW. (1976) Acute renal success: the unexpected logic of oliguria in acute renal failure. Am. J. Med. 61:308-15.
214. Macias WL, et al. (2005) New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated). Crit. Care 9 Suppl 4:S38-45.
215. Bernard GR, et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344:699-709.
216. Gupta A, Rhodes GJ, Berg DT, Gerlitz B, Molitoris BA, Grinnell BW. (2007) Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. Am. J. Physiol. Renal Physiol. 293:F245-54.
217. Gupta A, et al. (2007) Role of protein C in renal dysfunction after polymicrobial sepsis. J. Am. Soc. Nephrol. 18:860-7.
218. Dear JW, et al. (2006) Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis. Kidney Int. 69:832-6.
219. Ventura CG, Coimbra TM, de Campos SB, de Castro I, Yu L, Seguro AC. (2002) Mycophenolate mofetil attenuates renal ischemia/reperfusion injury. J. Am. Soc. Nephrol. 13:2524-33.
220. Ysebaert DK, et al. (2003) Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury. Kidney Int. 64:864-73.
221. Ricci Z, Cruz D, Ronco C. (2008) The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int. 73:538-46.
222. Bonventre JV. (2007) Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib. Nephrol. 156:213-9.